“Right to Try” Legislation Moving Through Congress: But Drug Companies and Some Patient Groups Want Changes

Benzer Materyaller

• Pharmacy Groups Want to Change The FDA’s REMS Authority: Battles Loom as Congress Aims to Pass a Major Bill by September 2012
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2012)
• Drug Industry Groups Oppose FDA “Quality Metrics” Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2017)
• Congress Likely to Rein In 340B Drug Discount Program: The HRSA’s Draft Guidance and a Proposed Rule Give Legislators an Opening
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2015)
• FDA Wants Companies to Simplify Drug Packaging, Naming, and Labeling To Reduce Medication Errors
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2010)
• Pharmacists Step Up Efforts to Combat Opioid Abuse: The CDC and Congress Are Trying to Pitch In
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2015)